Depatuxizumab
- Product Name
- Depatuxizumab
- CAS No.
- 1471999-69-5
- Chemical Name
- Depatuxizumab
- Synonyms
- Depatuxizumab;Depatuxizumab (anti-EGFR);Research Grade Depatuxizumab;Research Grade Depatuxizumab (DHB86908)
- CBNumber
- CB88080994
- Formula Weight
- 0
- MOL File
- Mol file
Depatuxizumab Property
- form
- Liquid
- color
- Colorless to light yellow
Depatuxizumab Chemical Properties,Usage,Production
Uses
Depatuxizumab is a brain-penetrant and humanized tumor-specific anti EGFR monoclonal antibody. Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR. Depatuxizumab can be used for research on cancer[1].
in vivo
Depatuxizumab (10, 40 mg/kg, i.p., three times a week for 2 weeks) inhibits tumor growth significantly in U87MGde2-7 glioblastoma multiforme (GBM) models and A431 squamous xenograft models of Nu/Nu mice[1].
Depatuxizumab (10, 40 mg/kg, i.p., three times a week for 2 weeks) inhibits tumor growth and pEGFR levels in EGFRvIII-positive GBM SN0199 PDX models of NSG mice[1].
Depatuxizumab (2-40 mg/kg, i.p., three times a week for 2 weeks) inhibits tumor growth with dose dependent manner in SCC15 xenograft models of SCID Beige mice[1].
| Animal Model: | U87MGde2-7 glioblastoma multiforme (GBM) model of Nu/Nu mice[1] |
| Dosage: | 10, 40 mg/kg, three times a week for 2 weeks |
| Administration: | Intraperitoneal injection (i.p.) |
| Result: | Inhibited tumor growth significantly more than Cetuximab (HY-P9905). Promoted a significant increase in TGI (tumor growth inhibition) when it combined with Temozolomide (HY-17364). |
| Animal Model: | EGFRvIII-positive GBM SN0199 PDX model, 3 to 5 mm3 passage 3 (P3) tumor fragments were s.c. trochar implanted in the right rear flank of NSG mice[1] |
| Dosage: | 10, 40 mg/kg, three times a week for 2 weeks |
| Administration: | Intraperitoneal injection (i.p.) |
| Result: | Inhibited tumor growth significantly and reduced levels of pEGFR. |
| Animal Model: | A431 squamous xenograft model of Nu/Nu mice[1] |
| Dosage: | 10, 40 mg/kg, three times a week for 2 weeks |
| Administration: | Intraperitoneal injection (i.p.) |
| Result: | Inhibited tumor growth with comparable activity to Cetuximab (HY-P9905) dosed in an equivalent manner at 10 mg/kg. Inhibited tumor growth by 58% at 40 mg/kg. |
| Animal Model: | SCC15 xenograft model of SCID Beige mice[1] |
| Dosage: | 2, 10, 20, 40 mg/kg, three times a week for 2 weeks |
| Administration: | Intraperitoneal injection (i.p.) |
| Result: | Inhibited tumor growth with dose manner. Reduced the level of pEGFR and total EGFR in time-dependent. Reduced cell proliferation as measured by phospho-histone H3. Increased apoptosis as measured by caspase-3 cleavage. Increased antitumor activity when it was combined with both Cisplatin(HY-17394) or/and 5-FU(HY-90006) at 10 mg/kg. |
References
[1] Reilly EB, et al. Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody. Mol Cancer Ther. 2015 May;14(5):1141-51. DOI:10.1158/1535-7163.MCT-14-0820
Depatuxizumab Preparation Products And Raw materials
Raw materials
Preparation Products
Depatuxizumab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 027-65317797 15926423062
- Fax
- QQ：422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9763
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 33175446423
- support@antibodysystem.com
- Country
- China
- ProdList
- 6739
- Advantage
- 58